Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries

2015/11/18 by Marc Mendelson, John-Arne Røttingen, John‐Arne Røttingen +8 · 3 citations
Economics, Econometrics and Finance · Immunology and Microbiology · Medicine · #Antibiotic Use and Resistance #Global Maternal and Child Health #Pharmaceutical Economics and Policy

paper · doi:10.1016/s0140-6736(15)00547-4

openalex publication_date 2015/11/18 · crossref created 2015/11/18 · crossref issued 2016/01/01 · crossref published 2016/01/01 · crossref published-print 2016/01/01 · crossref deposited 2018/09/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04 · crossref indexed 2026/08/04

Citations

• Association between point-of-care CRP testing and antibiotic prescribing in respiratory tract infections: a systematic review and meta-analysis of primary care studies
• Access to medicines from a health system perspective

Cited by

• Understanding the mechanisms and drivers of antimicrobial resistance
• Stemming the Superbug Tide
• Antibiotic [wikipedia]